Related Experiment Videos
Vitreous leptin levels in retinal disease
D Maberley1, J Z Cui, J A Matsubara
1Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada. crtg_vancouver@hotmail.com
Eye (London, England)
|July 30, 2005
Summary
Vitreous leptin levels are significantly elevated in patients with proliferative diabetic retinopathy (PDR), suggesting leptin plays a role in this retinal disease. Other retinopathies showed no significant difference in vitreous leptin levels compared to controls.
Area of Science:
- Ophthalmology
- Endocrinology
- Molecular Biology
Background:
- Leptin, a hormone involved in metabolism, has been implicated in various ocular conditions.
- Understanding the role of vitreous cytokines is crucial for retinal disease pathogenesis.
Purpose of the Study:
- To investigate the association between vitreous leptin concentrations and different retinal diseases.
- To determine if leptin levels are altered in proliferative diabetic retinopathy (PDR) and other retinopathies.
Main Methods:
- Vitreous samples were collected from patients diagnosed with PDR, other retinopathies (macular disease, neovascular maculopathies, retinal detachments, vascular occlusive disease), and controls.
- Vitreous leptin levels were quantified using established laboratory assays.
Main Results:
- Patients with PDR exhibited significantly higher average vitreous leptin levels (37.4 ng/ml) compared to those with proliferative vitreoretinopathy (PVR) (<1.0 ng/ml, P<0.05).
- No significant differences in vitreous leptin levels were observed between patients with PVR or macular disease and control subjects with retinal detachment only.
Conclusions:
- Vitreous leptin levels are elevated in the context of proliferative diabetic retinopathy.
- These findings suggest a potential active role for leptin in the development or progression of PDR.